| id | Study | Lib. in paper | Exposition period | Study type |
Control type |
Tags | OR 95%CI | x1/n1 x0/n0 | no cases | no exposed | ROB | Ref. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| S7434 R21894 |
Bérard, 2017 | Genital organs malformations | 1st trimester | retrospective cohort (claims database) | unexposed, sick | Adjustment: Yes Monotherapy: substance alone among all Antidep (SSRI, SNRI, ...) Unexposed sick: intermediate history of illness/treatment (3-12 months before pregnancy) | 0.79 [0.41;1.52] | -/1,132 -/14,847 | - | 1,132 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S5886 R14747 |
Ban (Controls unexposed, disease free), 2014 | Genital system malformations | 1st trimester | retrospective cohort (claims database) | unexposed, disease free excluded | Adjustment: Yes Monotherapy: substance alone among the specific class of antidep (SSRI, SNRI, ...) |
0.97 [0.40;2.37] excluded (control group) |
-/1,200 1,292/325,294 | - | 1,200 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S5887 R14762 |
Ban (Controls unexposed, sick), 2014 | Genital system malformations | 1st trimester | retrospective cohort (claims database) | unexposed, sick | Adjustment: Yes Monotherapy: substance alone among the specific class of antidep (SSRI, SNRI, ...) Unexposed sick: intermediate history of illness/treatment (3-12 months before pregnancy) | 0.81 [0.32;2.02] | -/1,200 67/13,432 | - | 1,200 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S6017 R15556 |
Jimenez-Solem (Controls unexposed, NOS), 2012 | Congenital malformations of the external genital organs | 1st trimester | population based cohort retrospective | unexposed (general population or NOS) excluded | Adjustment: Yes Monotherapy: substance alone among the specific class of antidep (SSRI, SNRI, ...) |
3.83 [1.71;8.57] excluded (control group) |
6/568 2,504/843,797 | 2,510 | 568 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S6022 R15623 |
Jimenez-Solem (Controls unexposed, sick), 2012 | Congenital malformations of the external genital organs | 1st trimester | population based cohort retrospective | unexposed, sick | Adjustment: No Monotherapy: substance alone among the specific class of antidep (SSRI, SNRI, ...) Unexposed sick: intermediate history of illness/treatment (3-12 months before pregnancy) | 4.29 [0.86;21.34] C | 6/568 2/806 | 8 | 568 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S7228 R20764 |
Davis, 2007 | Congenital anomalies of genital organs | 1st trimester | retrospective cohort (claims database) | unexposed (general population or NOS) | Adjustment: No Monotherapy: no or not specified | 0.43 [0.11;1.71] | 2/182 1,166/49,654 | 1,168 | 182 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Total | 4 studies | 0.90 [0.46;1.76] | 1,176 | 3,082 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| x1: number of endpoints among exposed, n1: number of exposed; x0: number of endpoints among non exposed, n0: number of non exposed; C: calculated odds ratio from numbers of events and effectives | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1: Controls unexposed, sick; 2: Controls unexposed, sick;
Asymetry test p-value = NaN (by Egger's regression)
not enought points
excluded 6017, 5886